Akebia Therapeutics shares owned by UBS Group
Quarter-by-quarter ownership of Akebia Therapeutics (AKBA) shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Akebia Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Akebia Therapeutics held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Akebia Therapeutics by UBS Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $10M | 3.6M | 2.73 |
| 2025-06-30 | $2.3M | 640k | 3.64 |
| 2025-03-31 | $1.1M | 592k | 1.92 |
| 2024-12-31 | $667k | 351k | 1.90 |
| 2024-09-30 | $203k | 154k | 1.32 |
| 2024-06-30 | $146k | 143k | 1.02 |
| 2024-03-31 | $182k | 99k | 1.83 |
| 2023-12-31 | $157k | 157k | 1.00 |
| 2023-09-30 | $78k | 69k | 1.14 |
| 2023-06-30 | $65k | 72k | 0.92 |
| 2023-03-31 | $49k | 88k | 0.56 |
| 2022-12-31 | $34k | 59k | 0.58 |
| 2022-09-30 | $37k | 132k | 0.28 |
| 2022-06-30 | $45k | 131k | 0.35 |
| 2022-03-31 | $553k | 769k | 0.72 |
| 2021-12-31 | $1.1M | 483k | 2.26 |
| 2021-09-30 | $1.5M | 529k | 2.88 |
| 2021-06-30 | $524k | 138k | 3.79 |
| 2021-03-31 | $1.1M | 328k | 3.39 |
| 2020-12-31 | $381k | 136k | 2.80 |
| 2020-09-30 | $427k | 170k | 2.51 |
| 2020-06-30 | $1.8M | 130k | 13.58 |
| 2020-03-31 | $1.2M | 158k | 7.58 |
| 2019-12-31 | $1.4M | 223k | 6.32 |
| 2019-09-30 | $1.2M | 317k | 3.92 |
| 2019-06-30 | $1.2M | 255k | 4.84 |
| 2019-03-31 | $1.2M | 148k | 8.26 |
| 2018-12-31 | $1.0M | 184k | 5.54 |
| 2018-09-30 | $1.4M | 160k | 8.83 |
| 2018-06-30 | $1.3M | 132k | 9.92 |
| 2018-03-31 | $1.8M | 192k | 9.54 |
| 2017-12-31 | $1.7M | 116k | 14.81 |
| 2017-09-30 | $1.5M | 76k | 19.66 |
| 2017-06-30 | $1.6M | 111k | 14.37 |
| 2017-03-31 | $1.4M | 152k | 9.20 |
| 2016-12-31 | $882k | 85k | 10.41 |
| 2016-09-30 | $898k | 99k | 9.05 |
| 2016-06-30 | $774k | 104k | 7.48 |
| 2016-03-31 | $679k | 75k | 9.00 |
| 2015-12-31 | $1.2M | 91k | 12.92 |
| 2015-09-30 | $319k | 33k | 9.65 |
| 2015-03-31 | $130k | 12k | 10.98 |